DRUGS AFFECTING BLOOD CLOTTING AND FIBRINOLYSISLOELIGER EA.1980; SIDE EFF. DRUGS ANN.; NLD; DA. 1980; VOL. 4; PP. 244-251; BIBL. 70 REF.Article

THE ENIGMA OF CELERIO HYBR. PAULI MORY.LOELIGER EA.1976; T. ENTOMOL.; NEDERL.; DA. 1976; VOL. 119; NO 7; PP. 217-219; H.T. 1; BIBL. 2 REF.Serial Issue

REFERENCE PLASMAS IN THE LABORATORY CONTROL OF ORAL ANTICOAGULANTSMIALE JB; LOELIGER EA.1975; THROMBOSIS DIATHESIS HAEMORRHAG.; ALLEM.; DA. 1975; VOL. 33; NO 2; PP. 163-164; BIBL. 2REF.Article

PROGRESS IN LABORATORY CONTROL OF ORAL ANTICOAGULANTSLOELIGER EA; LEWIS SM.1982; LANCET (THE). (BRITISH EDITION); ISSN 0140-6736; GBR; DA. 1982; NO 8293; PP. 318-320; BIBL. 20 REF.Article

COUMARIN-ASSOCIATED HEPATITIS: REPORT OF TWO CASESSLAGBOOM G; LOELIGER EA.1980; ARCH. INTERN. MED. (1960); ISSN 0003-9926; USA; DA. 1980; VOL. 140; NO 8; PP. 1028-1029; BIBL. 3 REF.Article

RISKS OF LONG-TERM ORAL ANTICOAGULANT THERAPY IN ELDERLY PATIENTS AFTER MYOCARDIAL INFARCTION. SECOND REPORT OF THE SIXTY PLUS REINFARCTION STUDY RESEARCH GROUPWINTZEN AR; LOELIGER EA.1982; LANCET (BR. ED.); ISSN 0140-6736; GBR; DA. 1982; NO 8263; PP. 64-68; BIBL. 17 REF.Article

CIRCULATING ANTICUAGULANT IN DISSEMINATED LUPUS ERYTHEMATOSUS. PROPOSED MODE OF ACTION = ANTICOAGULANT CIRCULANT DANS LE LUPUS ERYTHEMATEUX DISSEMINE. MODE D'ACTION SUGGEREVELTKAMP JJ; KERKHOVEN P; LOELIGER EA et al.1973; HAEMOSTASIS; SWITZ.; DA. 1973; VOL. 2; NO 6; PP. 253-259; BIBL. 1 P. 1/2Article

A SIMPLIFIED THROMBOPLASTIN CALIBRATION PROCEDURE FOR STANDARDIZATION OF ANTICOAGULANT CONTROLLOELIGER EA; VAN HALEM VISSER LP.1975; THROMBOSIS DIATHESIS HAEMORRHAG.; ALLEM.; DA. 1975; VOL. 33; NO 2; PP. 172-190; ABS. FR. ALLEM.; BIBL. 1P.Article

SALICYLATE INDUCED-CONSUMPTION COAGULOPATHY = COAGULOPATHIE DE CONSOMMATION INDUITE PAR LES SALICYLESPINEDO HM; VAN DE PUTTE LBA; LOELIGER EA et al.1973; ANN. RHEUMAT. DIS.; G.B.; DA. 1973; VOL. 32; NO 1; PP. 66-68; BIBL. 11REF.Serial Issue

SPECTROPHOTOMETRIC ASSAYS OF PROTHROMBIN IN PLASMA OF PATIENTS USING ORAL ANTICOAGULANTSBERTINA RM; VAN DER MAREL VAN NIEUWKOOP W; LOELIGER EA et al.1979; THROMBOSIS AND HAEMOSTASIS; DEU; DA. 1979; VOL. 42; NO 4; PP. 1296-1305; BIBL. 17 REF.Article

INTERLABORATORY ORAL ANTICOAGULANT QUALITY ASSESSMENT BY THE NETHERLANDS FEDERATION OF THROMBOSIS SERVICES.VAN DUK WIERDA CA; HERMANS J; LOELIGER EA et al.1977; THROMBOSIS AND HAEMOSTASIS; GERM.; DA. 1977; VOL. 37; NO 3; PP. 509-522; ABS. FR. ALLEM.; BIBL. 22 REF.Article

CONTROLE DE QUALITE ET STANDARDISATION DE LA MESURE DU TEMPS DE PROTHROMBINE.LOELIGER EA; VAN DIJK WIERDA CA; ROOS J et al.1977; NOUV. REV. FR. HEMATOL.; FR.; DA. 1977; VOL. 18; NO 3; PP. 661-664; BIBL. 2 REF.Article

THE DUTCH SYSTEM. COUMARIN-PLASMA POOLS AS A TOOL IN PROTHROMBIN TIME STANDARDIZATION = LE SYSTEME HOLLANDAIS. LES MELANGES DE PLASMAS RENFERMANT DE LA COUMARINE COMME INSTRUMENT DANS LA NORMALISATION DU TEMPS DE PROTHROMBINELOELIGER EA; BUYTENDIJK FJJ; REITSMA G et al.1972; THROMBOSIS DIATHESIS HAEMORRHAG., SUPPL.; ALLEM.; DA. 1972; NO 51; PP. 331-334; BIBL. 6REF.Serial Issue

SUCCESSFUL PREVENTION OF COUMARIN-INDUCED HEMORRHAGIC SKIN NECROSIS BY TIMELY ADMINISTRATION OF VITAMIN K₁.VAN AMSTEL WJ; BOEKHOUT MUSSERT MJ; LOELIGER EA et al.1978; BLUT; DTSCH.; DA. 1978; VOL. 36; NO 2; PP. 89-93; ABS. ALLEM.; BIBL. 7 REF.Article

IS STREPTOKINASE USEFUL IN THE TREATMENT OF DEEP VEIN THROMBOSIS.BIEGER R; BOEKHOUT MUSSERT RJ; HOHMANN F et al.1976; ACTA MED. SCAND.; SUEDE; DA. 1976; VOL. 199; NO 1-2; PP. 81-88; BIBL. 23 REF.Article

MOLECULAR VARIANT OF FACTOR VII.BRIET E; LOELIGER EA; VAN TILBURG NH et al.1976; THROMBOSIS AND HAEMOSTASIS; GERM.; DA. 1976; VOL. 35; NO 2; PP. 289-294; ABS. FR. ALLEM.; BIBL. 20 REF.Article

QUALITAETSKONTROLLE UND STANDARDISIERUNG DER PROTHROMBINZEITBESTIMMUNG ZUR KONTROLLE ORALER ANTIKOAGULATION. = CONTROLE DE QUALITE STANDARDISATION DE LA DETERMINATION DU TEMPS DE PROTHROMBINE POUR LE CONTROLE DU TRAITEMENT ANTICOAGULANT ORALLOELIGER EA; VAN DIJK WIERDA CA; ROOS J et al.1977; BLUT; DTSCH.; DA. 1977; VOL. 34; NO 2; PP. 147-157; BIBL. 2 P. 1/2Article

ANTITHROMBIN AND ANTITHROMBOPLASTIN ACTIVITY ACCOMPANYING IGG MYELOMAHENSEN A; LOELIGER EA; HARBAUGH ME et al.1975; AMER. J. CLIN. PATHOL.; U.S.A.; DA. 1975; VOL. 64; NO 6; PP. 820-822; BIBL. 13 REF.Article

PROSPECTIVE DOUBLE-BLIND CLINICAL TRIAL OF BOVINE, HUMAN AND RABBIT THROMBOPLASTINS IN MONITORING LONG-TERM ORAL ANTICOAGULATIONBOEKHOUT MUSSERT MJ; VAN DER KOLK SCHAAP PJ; HERMANS J et al.1981; AM. J. CLIN. PATHOL.; ISSN 0002-9173; USA; DA. 1981; VOL. 75; NO 3; PP. 297-303; BIBL. 12 REF.Article

ARTERIAL THROMBOEMBOLIC COMPLICATIONS WITH AORTIC BALL VALVE PROSTHESES.BOEKHOUT MUSSERT MJ; BRIET E; VAN BRUMMELEN P et al.1978; AMER. HEART J.; U.S.A.; DA. 1978; VOL. 95; NO 2; PP. 270-272; BIBL. 28 REF.Article

THE PREPARATION OF CONTROL BLOOD FOR EXTERNAL QUALITY ASSESSMENT PROGRAMS IN ORAL ANTICOAGULANT CONTROL.VAN DIJK WIERDA CA; VAN HALEM VISSER LP; VAN DER HOFF VAN HALEM R et al.1978; THROMBOSIS AND HAEMOSTASIS; DEU; DA. 1978; VOL. 39; NO 1; PP. 210-214; ABS. FR. ALLEM.; BIBL. 9 REF.Article

STABILITY OF INTERNATIONAL REFERENCE THROMBOPLASTINSVAN DEN BESSELAAR AMHP; VAN HALEM VISSER LP; LOELIGER EA et al.1980; BRIT. J. HAEMATOL.; GBR; DA. 1980; VOL. 45; NO 1; PP. 153-160; BIBL. 9 REF.Article

SIMPLIFIED THROMBOPLASTIN CALIBRATION: FURTHER EXPERIENCE OF THE DUTCH REFERENCE LABORATORY FOR ANTICOAGULANT CONTROLVAN DEN BESSELAAR AMHP; VAN HALEM VISSER LP; HOEKSTRA SCHUMAN M et al.1980; THROMB. HAEMOST.; ISSN 0340-6245; DEU; DA. 1980; VOL. 43; NO 1; PP. 53-57; BIBL. 5 REF.Article